ecrin-mdr-crcClinical2011Colorectal CancerColorectal NeoplasmsColorectal CancerColorectal NeoplasmsObservationalhttps://newmdr.ecrin.org/Study/2110140Slovakia7OxaliplatinCapecitabineBevacizumabECRIN MDRCompletedfalseAn Observational Study of Avastin (Bevacizumab) in Combination With Xeloda (Capecitabine) And Oxaliplatin in Patients With Colorectal CancerThis prospective observational study will evaluate the efficacy and safety of bevacizumab in combination with capecitabine and oxaliplatin as first-line treatment in participants with colorectal cancer. Data will be collected from each participant until disease progression occurs (for up to 30 months).2011-07-152110140NCT01399190